Ind-Swift Laboratories Limited

Ind-Swift Laboratories Limited (INDSWFTLAB) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

indswiftgroup.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-02

Stock price
₹366.85
Market cap
3,189 Cr
Stock P/E
54.2
P/B
2.21

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales290 Cr288 Cr393 Cr33 Cr12 Cr9 Cr138 Cr153 Cr153 Cr151 Cr170 Cr191 Cr
Operating expenses (approx.)224 Cr236 Cr431 Cr43 Cr24 Cr23 Cr147 Cr149 Cr151 Cr147 Cr149 Cr158 Cr
EBITDA66 Cr51 Cr-37 Cr-10 Cr-12 Cr-15 Cr-9 Cr4 Cr1 Cr4 Cr21 Cr33 Cr
OPM %22.7%17.8%-9.5%-29.4%-98.6%-167.7%-6.7%2.4%1.0%2.8%12.1%17.5%
Other income7 Cr7 Cr25 Cr11 Cr13 Cr14 Cr4 Cr15 Cr18 Cr28 Cr2 Cr8 Cr
Interest21 Cr21 Cr-11 Cr0.17 Cr0.41 Cr0.11 Cr-27 Cr1 Cr2 Cr0.67 Cr-2 Cr0.71 Cr
Depreciation13 Cr14 Cr13 Cr0.25 Cr0.22 Cr0.25 Cr7 Cr7 Cr7 Cr9 Cr8 Cr8 Cr
Profit before tax39 Cr24 Cr373 Cr0.91 Cr0.60 Cr-1 Cr230 Cr10 Cr10 Cr14 Cr12 Cr33 Cr
Tax %18.0%17.9%36.0%-3.2%30.9%100.6%3.6%16.3%22.4%29.5%-26.3%24.5%
Net profit32 Cr19 Cr239 Cr0.94 Cr0.41 Cr0.0062 Cr222 Cr9 Cr8 Cr10 Cr15 Cr25 Cr
EPS (₹)₹5.36₹3.29₹40.42₹0.16₹0.07₹0.00₹32.96₹1.28₹1.00₹1.17₹1.81₹2.84

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales757 Cr780 Cr891 Cr1,039 Cr1,207 Cr1,281 Cr562 Cr641 CrSign in for TTM
Operating expenses (approx.)620 Cr635 Cr709 Cr842 Cr978 Cr1,027 Cr581 Cr596 CrSign in for TTM
EBITDA136 Cr144 Cr183 Cr196 Cr229 Cr254 Cr-19 Cr45 CrSign in for TTM
OPM %18.0%18.5%20.5%18.9%19.0%19.8%-3.5%7.0%Sign in for TTM
Other income27 Cr33 Cr23 Cr43 Cr34 Cr45 Cr81 Cr47 CrSign in for TTM
Interest83 Cr107 Cr100 Cr96 Cr92 Cr51 Cr3 Cr1 CrSign in for TTM
Depreciation104 Cr90 Cr87 Cr131 Cr57 Cr53 Cr24 Cr31 CrSign in for TTM
Profit before tax59 Cr-20 Cr18 Cr13 Cr86 Cr573 Cr258 Cr49 CrSign in for TTM
Tax %35.0%-7.2%117.5%117.1%44.8%26.4%2.8%15.7%Sign in for TTM
Net profit38 Cr-21 Cr-3 Cr-2 Cr48 Cr421 Cr250 Cr41 CrSign in for TTM
EPS (₹)₹10.28₹-4.28₹-0.53₹-0.36₹8.06₹71.24₹37.25₹4.95Sign in for TTM
Dividend payout %————0.0%0.0%0.0%0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital48 Cr60 Cr60 Cr60 Cr60 Cr59 Cr69 Cr87 Cr
Reserves556 Cr581 Cr544 Cr541 Cr622 Cr872 Cr1,104 Cr1,297 Cr
Borrowings1,058 Cr1,031 Cr1,005 Cr953 Cr862 Cr17 Cr41 Cr18 Cr
Other liabilities252 Cr199 Cr210 Cr247 Cr281 Cr217 Cr225 Cr271 Cr
Total liabilities1,914 Cr1,870 Cr1,818 Cr1,801 Cr1,824 Cr1,165 Cr1,438 Cr1,673 Cr
Fixed assets (net)832 Cr796 Cr735 Cr628 Cr583 Cr5 Cr260 Cr275 Cr
CWIP13 Cr4 Cr11 Cr9 Cr8 Cr——10 Cr
Investments31 Cr30 Cr50 Cr32 Cr33 Cr113 Cr216 Cr250 Cr
Inventories329 Cr343 Cr376 Cr429 Cr439 Cr10 Cr114 Cr148 Cr
Trade receivables351 Cr396 Cr432 Cr455 Cr505 Cr169 Cr165 Cr199 Cr
Cash & bank30 Cr11 Cr12 Cr21 Cr18 Cr432 Cr428 Cr430 Cr
Other assets329 Cr291 Cr202 Cr227 Cr238 Cr435 Cr256 Cr362 Cr
Total assets1,914 Cr1,870 Cr1,818 Cr1,801 Cr1,824 Cr1,165 Cr1,438 Cr1,673 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———150 Cr195 Cr-181 Cr-25 Cr-63 Cr
Cash from investing———5 Cr-13 Cr-104 Cr-110 Cr-73 Cr
Cash from financing———-141 Cr-186 Cr699 Cr69 Cr142 Cr
Net cash flow———14 Cr-4 Cr413 Cr-66 Cr11 Cr
Free cash flow (OCF − Capex)———132 Cr182 Cr-225 Cr-90 Cr-151 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %8.6%21.1%7.4%26.8%11.6%65.8%21.5%3.6%
ROE %6.4%-5.1%0.0%-0.5%0.0%0.0%0.0%0.0%
Debtor days16918617715915248107113
Inventory days2883063012762436185198
Days payable11112111111311357179195
Cash conversion cycle346371367322282-3113115
Debt / equity1.751.611.671.591.260.020.030.01
Current ratio2.502.673.003.213.142.993.923.83
Net debt / EBITDA0.000.005.430.003.68-1.63—-9.13

Compare with peers

Loading peers…

Ind-Swift Laboratories Limited (INDSWFTLAB) Financials | BullKarma